Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

ASX Announcements 2005

  • 30 Nov 2005

    Biotron’s HIV drug improves activity of existing HIV therapies

  • 25 Oct 2005

    Quarterly Report 30 September 2005

  • 24 Oct 2005

    Directors’ Interests

  • 21 Oct 2005

    Options

  • 14 Oct 2005

    Annual General Meeting

  • 14 Oct 2005

    Presentation to Annual General Meeting

  • 29 Sep 2005

    Annual report for the year ended 30 June 2005

  • 13 Sep 2005

    Preliminary Final Report for year ended 30 June 2005

  • 8 Sep 2005

    Lead HIV Drug Selected to Progress Into Human Trials

  • 17 Aug 2005

    Biotron Compound Active Against Resistant HIV

  • 15 Aug 2005

    Passing of Professor Peter Gage

  • 30 Jun 2005

    Quarterly Report 30 June 2005

  • 11 May 2005

    C-Test Project Developments

  • 4 May 2005

    Virion Project Developments

  • 21 Apr 2005

    Quarterly Report 31 March 2005

  • 25 Feb 2005

    Half-year report 31 December 2004

  • 28 Jan 2005

    Quarterly Report 31 December 2004

  • <<
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • >>

Investor Centre

  • Investor Centre
    • ASX Announcements
    • Annual reports
    • Corporate Directory
    • Shareholder services
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 30 May 2022        Legal Notices and Privacy